Let-7 Family as a Mediator of Exercise on Alzheimer's Disease
- PMID: 40389769
- PMCID: PMC12089606
- DOI: 10.1007/s10571-025-01559-9
Let-7 Family as a Mediator of Exercise on Alzheimer's Disease
Abstract
Memory loss, and behavioral impairments. Hallmark pathological features include amyloid-beta (Aβ) plaques, tau neurofibrillary tangles, chronic inflammation, and impaired neuronal signaling. Physical exercise is increasingly recognized as a non-pharmacological intervention to attenuate Alzheimer's disease (AD) risk and progression by enhancing neuroplasticity, improving mitochondrial function, and modulating immune responses. The let-7 family of microRNAs is critically involved in AD pathology. Elevated levels of let-7b and let-7e have been reported in the cerebrospinal fluid of AD patients, with let-7b levels correlating positively with total tau and phosphorylated tau concentrations. Overexpression of let-7a enhances Aβ-induced neurotoxicity, increases neuronal apoptosis by up to 45%, and alters autophagy-related signaling via the PI3K/Akt/mTOR pathway, as shown by 1.8-fold increases in LC3-II/I ratios and 2.2-fold upregulation of Beclin-1 expression. Exercise modulates let-7 expression in a tissue-specific and context-dependent manner. Aerobic training reduces skeletal muscle expression of let-7b-5p by 30-35%, while increasing its suppressor Lin28a by 40%, thereby improving mitochondrial respiration. Overall, modulation of let-7 by exercise influences neuronal survival, autophagy, and inflammation, offering a potential mechanism through which physical activity exerts neuroprotective effects in AD. Quantitative characterization of let-7 expression patterns may support its use as a diagnostic and therapeutic biomarker, though further research is needed to establish optimal modulation strategies.
Keywords: Alzheimer’s disease; Exercise; Let-7; MicroRNAs.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable.
Similar articles
-
Inhibiting Autophagy Pathway of PI3K/AKT/mTOR Promotes Apoptosis in SK-N-SH Cell Model of Alzheimer's Disease.J Healthc Eng. 2022 Feb 8;2022:6069682. doi: 10.1155/2022/6069682. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Jan 19;2023:9780432. doi: 10.1155/2023/9780432. PMID: 35178230 Free PMC article. Retracted.
-
Overexpression of let-7a increases neurotoxicity in a PC12 cell model of Alzheimer's disease via regulating autophagy.Exp Ther Med. 2017 Oct;14(4):3688-3698. doi: 10.3892/etm.2017.4977. Epub 2017 Aug 21. Exp Ther Med. 2017. PMID: 29042965 Free PMC article.
-
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1. Prog Neurobiol. 2013. PMID: 23827971 Review.
-
Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway.Biomed Pharmacother. 2024 Jul;176:116836. doi: 10.1016/j.biopha.2024.116836. Epub 2024 Jun 7. Biomed Pharmacother. 2024. PMID: 38850660
-
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488. Cells. 2019. PMID: 31121890 Free PMC article. Review.
References
-
- Alzheimer’s Association (2020) Alzheimer’s disease facts and figures. Alzheimers Dement - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous